表紙:ウェスタンブロッティング (WB) の世界市場 - 2026年までの予測:製品別 (消耗品 (抗体)、機器 (電気泳動、ブロッティングシステム、イメージャー))、用途別 (バイオメディカル、臨床診断)、エンドユーザー別
市場調査レポート
商品コード
1037526

ウェスタンブロッティング (WB) の世界市場 - 2026年までの予測:製品別 (消耗品 (抗体)、機器 (電気泳動、ブロッティングシステム、イメージャー))、用途別 (バイオメディカル、臨床診断)、エンドユーザー別

Western Blotting Market by Product, (Consumables(Antibody), Instrument (Electrophoresis, Blotting System, Imager(Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User(Research Institute, Hospital, Biopharma) - Global Forecast -2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 263 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
ウェスタンブロッティング (WB) の世界市場 - 2026年までの予測:製品別 (消耗品 (抗体)、機器 (電気泳動、ブロッティングシステム、イメージャー))、用途別 (バイオメディカル、臨床診断)、エンドユーザー別
出版日: 2021年11月16日
発行: MarketsandMarkets
ページ情報: 英文 263 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のウェスタンブロッティング (WB) の市場規模は、2021年の10億米ドルから、2026年までに14億米ドルに達し、予測期間中のCAGRで6.7%の成長が予測されています。

市場の成長を促進する主な要因は、技術の進歩、バイオメディカル研究分野における政府の資金援助の増加、個別化医療への需要の拡大、HIVの有病率の急増などです。

当レポートでは、世界のウェスタンブロッティング (WB) 市場について調査分析し、市場概要、業界動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • ウェスタンブロッティング (WB) 市場に対するCOVID-19の影響
  • 特許分析
  • 規制ガイドライン
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • ウェスタンブロッティング (WB) 市場のエコシステム分析
  • 技術分析
  • 範囲/シナリオ
  • 貿易分析
  • 顧客のビジネスに影響を与える動向/ディスラプション

第6章 ウェスタンブロッティング (WB) 市場:製品別

  • 消耗品
  • 機器

第7章 ウェスタンブロッティング (WB) 市場:用途別

  • バイオメディカル研究
  • 臨床診断
  • 農業用途
  • その他

第8章 ウェスタンブロッティング (WB) 市場:エンドユーザー別

  • 学術・研究機関
  • バイオ医薬品企業・バイオテクノロジー企業
  • 病院・診断研究所
  • その他

第9章 ウェスタンブロッティング (WB) 市場:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 主要企業戦略
  • ウェスタンブロッティング (WB) 市場の主要企業による戦略の概要
  • 市場シェア分析
  • 収益分析
  • 企業の評価象限
  • 競合リーダーシップマッピング (スタートアップ)
  • 競合ベンチマーキング
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • BIO-RAD LABORATORIES, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • DANAHER CORPORATION
    • BIO-TECHNE CORPORATION
    • MERCK KGAA
    • PERKINELMER, INC.
    • ABCAM PLC
    • ENZO BIOCHEM, INC.
    • LI-COR, INC.
    • ADVANSTA INC.
    • CELL SIGNALING TECHNOLOGY, INC.
    • AZURE BIOSYSTEMS, INC.
    • BOSTER BIOLOGICAL TECHNOLOGY
    • GENO TECHNOLOGY INC.
    • STRESSMARQ BIOSCIENCES INC.
  • その他の企業
    • F. HOFFMANN-LA ROCHE LTD.
    • ROCKLAND IMMUNOCHEMICALS, INC.
    • PRECISION BIOSYSTEMS
    • CLEAVER SCIENTIFIC LTD.
    • PROTEINTECH GROUP
    • ABNOVA CORPORATION
    • SINO BIOLOGICAL INC.
    • ABBEXA LTD.
    • COVALAB S.A.S.
    • BIORBYT LTD.

第12章 付録

目次
Product Code: BT 2613

The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

"By instruments segment, the imagers sub segment accounted for the fastest-growing segment of the western blotting market"

Based on instruments, the western blotting market is segmented into gel electrophoresis instruments, blotting systems, and imagers. Growth in this product segment is primarily due to the automation of imagers, which simplifies the protein detection process.

"By end user segment, the academic & research institutes segment accounted for the largest share of the western blotting market"

Based on end users, the western blotting market is segmented into academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and other end users In 2020, academic & research institutes accounted for the largest share of the western blotting market. The large share of the academic & research institutes end-user segment can be attributed to growing government investments for research activities and increasing research in the area of proteomics.

"Asia Pacific: The fastest-growing region in the western blotting market."

The western blotting market in the Asia Pacific region is projected to register the highest growth during the forecast period. The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bioclusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.

"North America: the largest share of the western blotting market"

In 2020, North America accounted for the largest share of the western blotting market. The major factors driving the growth of this regional market include the presence of top manufacturers of western blotting products in this region, rise in research funding, increasing investments in proteomics research, and growing focus on personalized medicine.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Respondent- Supply Side- 70%, Demand Side-30%
  • By Designation- CXOs and Directors- 30%, Executives - 25%, Mangers - 45%
  • By Region- North America - 40%, Europe - 25%, APAC - 20%, LATAM- 10% , MEA- 5%

Prominent players in the western blotting market include Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Bio-Techne Corporation (US), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Advansta Inc. (US), Cell Signaling Technology, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Azure Biosystems, Inc. (US), Boster Biological Technology (US), Geno Technology Inc. (US), Rockland Immunochemicals, Inc. (US), Precision Biosystems (US), Cleaver Scientific Ltd. (UK), Abcam Plc (UK), Proteintech Group (US), Enzo Biochem, Inc. (US), Abnova Corporation (Taiwan), Sino Biological Inc. (China), StressMarq Biosciences Inc. (Canada), Abbexa Ltd. (UK), Covalab S.A.S. (France), and Biorbyt Ltd. (UK).

Research Coverage:

The report segments the western blotting market based on region (the Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa), product (consumables [Reagents & Buffers, Antibodies & Conjugates {Primary Antibodies, Secondary Antibodies, Other Antibodies & Conjugates}, Kits

Membranes & Filter Papers Other Consumables], instruments [Electrophoresis, Blotting Systems {Semi-dry Blotting Systems, Wet Blotting Systems}, Imagers {Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers}]), application (Biomedical Research, Clinical Diagnostics [HIV, Lyme Disease, Hepatitis, Other Diseases], Agricultural Applications, Other Applications), and end-user (Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users). The report also provides a comprehensive review of market drivers, restraints opportunities, challenges and trends in the western blotting market.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the western blotting market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 WESTERN BLOTTING MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
    • FIGURE 4 WESTERN BLOTTING MARKET: BREAKDOWN OF PRIMARIES
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
    • FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP (SUPPLY SIDE) - COLLECTIVE REVENUE OF ALL WESTERN BLOTTING PRODUCTS
    • FIGURE 7 WESTERN BLOTTING MARKET: CAGR PROJECTIONS, 2021-2026
    • FIGURE 8 WESTERN BLOTTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 GROWTH RATE ASSUMPTIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 WESTERN BLOTTING MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 WESTERN BLOTTING MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 WESTERN BLOTTING MARKET SHARE, BY END USER, 2020
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE WESTERN BLOTTING MARKET

4 PREMIUM INSIGHTS

  • 4.1 WESTERN BLOTTING MARKET OVERVIEW
    • FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND GROWING DEMAND FOR PERSONALIZED MEDICINE ARE KEY FACTORS DRIVING GROWTH IN THE WESTERN BLOTTING MARKET
  • 4.2 ASIA PACIFIC: WESTERN BLOTTING MARKET, BY END USER & COUNTRY (2020)
    • FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2020
  • 4.3 WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2020
    • FIGURE 16 THE BLOTTING SYSTEMS SEGMENT DOMINATED THE MARKET IN 2020
  • 4.4 WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2020
    • FIGURE 17 THE SEMI-DRY BLOTTING SYSTEMS SEGMENT IS PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 4.5 WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2020
    • FIGURE 18 THE CHEMILUMINESCENT IMAGERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE WESTERN BLOTTING MARKET IN 2020

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 WESTERN BLOTTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Technological advancements
      • 5.2.1.2 Increasing government funding in the field of biomedical research
      • 5.2.1.3 Growing demand for personalized medicine
    • FIGURE 20 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008-2020
      • 5.2.1.4 Rising global prevalence and incidence of HIV/AIDS
    • TABLE 1 INCIDENCE OF HIV/AIDS, BY REGION, 2020
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Emergence of alternative technologies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Requirement of high procedural efficiency for accurate results
  • 5.3 IMPACT OF COVID-19 ON THE WESTERN BLOTTING MARKET
  • 5.4 PATENT ANALYSIS
    • 5.4.1 NUMBER OF PUBLICATIONS OVER THE LAST 10 YEARS
    • 5.4.2 TOP 10 GRANTED PATENT OWNERS IN THE LAST 20 YEARS
    • 5.4.3 TOP 10 PLAYERS WITH THE HIGHEST NO. OF PATENT APPLICATIONS
    • 5.4.4 LIST OF RECENT PATENTS
  • 5.5 REGULATORY GUIDELINES
    • 5.5.1 NORTH AMERICA
    • 5.5.2 EUROPE
    • 5.5.3 EMERGING MARKETS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 22 DIRECT DISTRIBUTION-THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 WESTERN BLOTTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 DEGREE OF COMPETITION
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT FROM SUBSTITUTES
    • 5.8.5 THREAT FROM NEW ENTRANTS
  • 5.9 ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET
    • FIGURE 23 ECOSYSTEM ANALYSIS OF THE WESTERN BLOTTING MARKET
    • 5.9.1 ROLE IN THE ECOSYSTEM
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 ALTERNATIVES TO TRADITIONAL WESTERN BLOTTING
  • 5.11 RANGES/SCENARIOS
    • FIGURE 24 DEPENDING ON HOW THE UNCERTAINTIES UNFOLD, WE SEE A SPECTRUM OF SCENARIOS FOR THE WESTERN BLOTTING MARKET
  • 5.12 TRADE ANALYSIS
    • 5.12.1 TRADE ANALYSIS FOR WESTERN BLOTTING
    • TABLE 3 IMPORT DATA FOR HS CODE 90278090, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 4 EXPORT DATA FOR HS CODE 90278090, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS

6 WESTERN BLOTTING MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 6 WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 7 WESTERN BLOTTING CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 8 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 9 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 10 APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.1 REAGENTS & BUFFERS
      • 6.2.1.1 High consumption of reagents & buffers during the western blot process to drive market growth
    • TABLE 11 WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 12 NORTH AMERICA: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 13 EUROPE: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 14 APAC: WESTERN BLOTTING MARKET FOR REAGENTS & BUFFERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.2 ANTIBODIES & CONJUGATES
    • TABLE 15 WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 16 WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 17 NORTH AMERICA: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 18 EUROPE: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 19 APAC: WESTERN BLOTTING MARKET FOR ANTIBODIES & CONJUGATES, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.2.2.1 Primary antibodies
        • 6.2.2.1.1 Primary antibodies are mainly used to recognize a specific protein of interest
    • TABLE 20 WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 21 NORTH AMERICA: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 22 EUROPE: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 23 APAC: WESTERN BLOTTING MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.2.2.2 Secondary antibodies
        • 6.2.2.2.1 High sensitivity of secondary antibodies makes it easier to detect proteins of interest in complex protein mixtures
    • TABLE 24 WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 25 NORTH AMERICA: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 26 EUROPE: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 27 APAC: WESTERN BLOTTING MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.2.2.3 Other antibodies & conjugates
    • TABLE 28 WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 30 EUROPE: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 31 APAC: WESTERN BLOTTING MARKET FOR OTHER ANTIBODIES & CONJUGATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.3 KITS
      • 6.2.3.1 Repeat purchases of single-use ready-to-use kits to drive market growth
    • TABLE 32 WESTERN BLOTTING MARKET FOR KITS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 33 NORTH AMERICA: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 34 EUROPE: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 35 APAC: WESTERN BLOTTING MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.4 MEMBRANES & FILTER PAPERS
      • 6.2.4.1 Extensive usage of membranes & filter papers to support the immobilization and transfer steps during western blotting experiments to drive market growth
    • TABLE 36 COMPARISON OF NITROCELLULOSE MEMBRANES AND PVDF MEMBRANES
    • TABLE 37 WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 38 NORTH AMERICA: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 39 EUROPE: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 40 APAC: WESTERN BLOTTING MARKET FOR MEMBRANES & FILTER PAPERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.2.5 OTHER CONSUMABLES
    • TABLE 41 WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 42 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 43 EUROPE: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 44 APAC: WESTERN BLOTTING MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 45 WESTERN BLOTTING INSTRUMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 46 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 47 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 48 APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 49 WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 6.3.1 GEL ELECTROPHORESIS INSTRUMENTS
      • 6.3.1.1 Increased demand for 2D electrophoresis due to its high separation performance is one of the major factors driving the growth of the market
    • TABLE 50 WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 52 EUROPE: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 53 APAC: WESTERN BLOTTING MARKET FOR GEL ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.2 BLOTTING SYSTEMS
    • TABLE 54 COMPARISON BETWEEN PROTEIN BLOTTING SYSTEMS
    • TABLE 55 WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 57 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 58 EUROPE: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 59 APAC: WESTERN BLOTTING MARKET FOR BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.3.2.1 Wet blotting systems
        • 6.3.2.1.1 Wet systems are most commonly used for the transfer of proteins from gels to membranes
    • TABLE 60 WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 61 NORTH AMERICA: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 62 EUROPE: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 63 APAC: WESTERN BLOTTING MARKET FOR WET BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.3.2.2 Semi-dry blotting systems
        • 6.3.2.2.1 Minimal usage of buffers during the process and rapid transfer of proteins from gels to membranes are major factors driving the demand for semi-dry blotting systems
    • TABLE 64 WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 65 NORTH AMERICA: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 66 EUROPE: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 67 APAC: WESTERN BLOTTING MARKET FOR SEMI-DRY BLOTTING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 6.3.3 IMAGERS
    • TABLE 68 WESTERN BLOTTING MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 69 WESTERN BLOTTING MARKET FOR IMAGERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 71 EUROPE: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 72 APAC: WESTERN BLOTTING MARKET FOR IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.3.3.1 Chemiluminescent imagers
        • 6.3.3.1.1 Low cost of these imagers, easy handling, and sensitivity are some of the key factors contributing to the large share of this market
    • TABLE 73 WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 74 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 75 EUROPE: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 76 APAC: WESTERN BLOTTING MARKET FOR CHEMILUMINESCENT IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.3.3.2 Fluorescent imagers
        • 6.3.3.2.1 Fluorescent imagers serve as one-stop imaging systems as they avoid multiple film exposures and development steps
    • TABLE 77 WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 78 NORTH AMERICA: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 79 EUROPE: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 80 APAC: WESTERN BLOTTING MARKET FOR FLUORESCENT IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
      • 6.3.3.3 Other imagers
    • TABLE 81 WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 82 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 EUROPE: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 84 APAC: WESTERN BLOTTING MARKET FOR OTHER IMAGERS, BY COUNTRY, 2019-2026 (USD MILLION)

7 WESTERN BLOTTING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 85 WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 7.2 BIOMEDICAL RESEARCH
    • 7.2.1 INCREASING RESEARCH FUNDING FOR PROTEOMICS AND PROTEIN-BASED RESEARCH-A MAJOR DRIVER FOR THIS APPLICATION SEGMENT
    • TABLE 86 WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 87 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 88 EUROPE: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 89 APAC: WESTERN BLOTTING MARKET FOR BIOMEDICAL RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.3 CLINICAL DIAGNOSTICS
    • TABLE 90 WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 91 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 93 APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 94 WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • 7.3.1 HIV
      • 7.3.1.1 Western blotting is the most widely used method for HIV diagnosis- a key factor driving market growth
    • TABLE 95 WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 96 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 97 EUROPE: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 98 APAC: WESTERN BLOTTING MARKET FOR HIV DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.2 HEPATITIS
      • 7.3.2.1 Growing incidence of hepatitis C to drive market growth
    • TABLE 99 WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 100 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 101 EUROPE: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 102 APAC: WESTERN BLOTTING MARKET FOR HEPATITIS DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.3 LYME DISEASE
      • 7.3.3.1 Western blots are generally considered the most reliable tests currently available for Lyme disease diagnosis
    • TABLE 103 WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 104 NORTH AMERICA: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 105 EUROPE: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 106 APAC: WESTERN BLOTTING MARKET FOR LYME DISEASE DIAGNOSIS, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.3.4 OTHER DISEASES
    • TABLE 107 WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 108 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 EUROPE: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 110 APAC: WESTERN BLOTTING MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 AGRICULTURAL APPLICATIONS
    • 7.4.1 GROWING CULTIVATION OF GENETICALLY MODIFIED CROPS TO DRIVE MARKET GROWTH
    • TABLE 111 WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 112 NORTH AMERICA: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 113 EUROPE: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 114 APAC: WESTERN BLOTTING MARKET FOR AGRICULTURAL APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 OTHER APPLICATIONS
    • TABLE 115 WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 116 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 117 EUROPE: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 118 APAC: WESTERN BLOTTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)

8 WESTERN BLOTTING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 119 WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 ACADEMIC & RESEARCH INSTITUTES
    • 8.2.1 INCREASING GOVERNMENT INVESTMENTS FOR RESEARCH ACTIVITIES TO DRIVE GROWTH IN THIS MARKET SEGMENT
    • TABLE 120 WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 121 NORTH AMERICA: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 122 EUROPE: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 123 APAC: WESTERN BLOTTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.3.1 GROWING DRUG DISCOVERY AND CLINICAL STUDIES TO DRIVE THE DEMAND FOR WESTERN BLOTTING IN THE PHARMA-BIOTECH INDUSTRY
    • TABLE 124 WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 125 NORTH AMERICA: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 126 EUROPE: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 127 APAC: WESTERN BLOTTING MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.4 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 8.4.1 GROWING PATIENT POPULATION AND TESTING VOLUMES TO DRIVE MARKET GROWTH
    • TABLE 128 WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 129 NORTH AMERICA: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 130 EUROPE: WESTERN BLOTTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 131 APAC: WESTERN BLOTTING FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 132 WESTERN BLOTTING MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 133 NORTH AMERICA: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 134 EUROPE: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 135 APAC: WESTERN BLOTTING MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)

9 WESTERN BLOTTING MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: WESTERN BLOTTING MARKET SNAPSHOT
    • TABLE 136 NORTH AMERICA: WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 137 NORTH AMERICA: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 138 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 140 NORTH AMERICA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 142 NORTH AMERICA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 NORTH AMERICA: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 144 NORTH AMERICA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 NORTH AMERICA: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American western blotting market
    • TABLE 146 US: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 147 US: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 148 US: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 149 US: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 150 US: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 US: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 152 US: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 153 US: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 US: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Strong infrastructure and availability of funding for biomedical research to support market growth in Canada
    • TABLE 155 CANADA: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 156 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 157 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 CANADA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 CANADA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 CANADA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 161 CANADA: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 162 CANADA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 163 CANADA: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 164 EUROPE: WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 165 EUROPE: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 166 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 168 EUROPE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 169 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 EUROPE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 171 EUROPE: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 172 EUROPE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 173 EUROPE: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany is the largest market for western blotting in Europe
    • TABLE 174 GERMANY: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 175 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 GERMANY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 GERMANY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 179 GERMANY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 180 GERMANY: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 181 GERMANY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 182 GERMANY: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Proteomics research in France is strongly supported by the government-a key factor driving market growth
    • TABLE 183 FRANCE: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 184 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 185 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 FRANCE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 FRANCE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 188 FRANCE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 189 FRANCE: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 190 FRANCE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 191 FRANCE: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Government support for disease diagnostics and the favorable investment scenario to drive the market in the UK
    • TABLE 192 UK: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 193 UK: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 UK: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 UK: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 197 UK: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 198 UK: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 199 UK: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 200 UK: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growth in this market is mainly driven by increasing life science R&D in the country
    • TABLE 201 ITALY: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 202 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 204 ITALY: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 205 ITALY: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 206 ITALY: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 207 ITALY: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 208 ITALY: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 209 ITALY: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Well-established network for translational medicine research to drive market growth in Spain
    • TABLE 210 SPAIN: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 211 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 212 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 213 SPAIN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 214 SPAIN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 215 SPAIN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 216 SPAIN: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 217 SPAIN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 218 SPAIN: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE (ROE)
    • TABLE 219 ROE: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 220 ROE: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 221 ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 222 ROE: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 223 ROE: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 ROE: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 225 ROE: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 226 ROE: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 227 ROE: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: WESTERN BLOTTING MARKET SNAPSHOT
    • TABLE 228 APAC: WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 229 APAC: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 230 APAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 231 APAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 232 APAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 233 APAC: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 234 APAC: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 235 APAC: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 236 APAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 237 APAC: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Growing research initiatives towards the development of precision medicine are supporting market growth in Japan
    • TABLE 238 JAPAN: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 239 JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 241 JAPAN: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 242 JAPAN: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 243 JAPAN: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 244 JAPAN: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 245 JAPAN: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 246 JAPAN: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing government support for the biomedical and biotechnology industries to drive market growth
    • TABLE 247 CHINA: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 248 CHINA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 249 CHINA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 250 CHINA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 251 CHINA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 CHINA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 253 CHINA: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 254 CHINA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 255 CHINA: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Growing pharmaceutical & biotechnology industry in India, backed by government initiatives, to drive market growth
    • TABLE 256 INDIA: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 257 INDIA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 258 INDIA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 259 INDIA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 260 INDIA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 261 INDIA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 262 INDIA: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 263 INDIA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 264 INDIA: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 ROAPAC
    • TABLE 265 ROAPAC: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 266 ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 267 ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 268 ROAPAC: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 269 ROAPAC: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 270 ROAPAC: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 271 ROAPAC: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 272 ROAPAC: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 273 ROAPAC: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING ADOPTION OF PROTEOMICS TECHNOLOGIES IN THE REGION TO DRIVE MARKET GROWTH
    • TABLE 274 LATAM: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 275 LATAM: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 276 LATAM: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 277 LATAM: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 278 LATAM: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 279 LATAM: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 280 LATAM: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 281 LATAM: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 282 LATAM: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 PRESENCE OF A LARGER PATIENT POPULATION TO DRIVE THE MARKET IN THIS REGION
    • TABLE 283 MEA: WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 284 MEA: WESTERN BLOTTING INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 285 MEA: WESTERN BLOTTING INSTRUMENTS MARKET FOR BLOTTING SYSTEMS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 286 MEA: WESTERN BLOTTING INSTRUMENTS MARKET FOR IMAGERS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 287 MEA: WESTERN BLOTTING CONSUMABLES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 288 MEA: WESTERN BLOTTING CONSUMABLES MARKET FOR ANTIBODIES & CONJUGATES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 289 MEA: WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 290 MEA: WESTERN BLOTTING MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY DISEASE TYPE, 2019-2026 (USD MILLION)
    • TABLE 291 MEA: WESTERN BLOTTING MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 KEY PLAYER STRATEGIES
  • 10.2 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE WESTERN BLOTTING MARKET
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 27 WESTERN BLOTTING MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2020
    • TABLE 292 WESTERN BLOTTING MARKET: DEGREE OF COMPETITION
  • 10.4 REVENUE ANALYSIS
    • FIGURE 28 REVENUE ANALYSIS FOR KEY COMPANIES (2017-2020)
  • 10.5 COMPANY EVALUATION QUADRANT
    • FIGURE 29 WESTERN BLOTTING MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2020
    • 10.5.1 STARS
    • 10.5.2 PERVASIVE PLAYERS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PARTICIPANTS
  • 10.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS) (2020)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 RESPONSIVE COMPANIES
    • FIGURE 30 COMPETITIVE LEADERSHIP MAPPING: WESTERN BLOTTING MARKET
  • 10.7 COMPETITIVE BENCHMARKING
    • TABLE 293 COMPANY PRODUCT FOOTPRINT (25 COMPANIES)
    • TABLE 294 COMPANY REGIONAL FOOTPRINT (25 COMPANIES)
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • TABLE 295 WESTERN BLOTTING MARKET: PRODUCT LAUNCHES, JANUARY 2018-OCTOBER 2021
    • 10.8.2 DEALS
    • TABLE 296 WESTERN BLOTTING MARKET: DEALS, JANUARY 2018-OCTOBER 2021
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 297 WESTERN BLOTTING MARKET: OTHER DEVELOPMENTS, JANUARY 2018-OCTOBER 2021

11 COMPANY PROFILES

  • 11.1 KEY COMPANIES
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 11.1.1 BIO-RAD LABORATORIES, INC.
    • TABLE 298 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 31 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)
    • 11.1.2 THERMO FISHER SCIENTIFIC INC.
    • TABLE 299 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 32 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. (2020)
    • 11.1.3 DANAHER CORPORATION
    • TABLE 300 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 33 COMPANY SNAPSHOT: DANAHER CORPORATION (2020)
    • 11.1.4 BIO-TECHNE CORPORATION
    • TABLE 301 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021)
    • 11.1.5 MERCK KGAA
    • TABLE 302 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 35 COMPANY SNAPSHOT: MERCK KGAA (2020)
    • 11.1.6 PERKINELMER, INC.
    • TABLE 303 PERKINELMER, INC.: BUSINESS OVERVIEW
    • FIGURE 36 PERKINELMER, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.7 ABCAM PLC
    • TABLE 304 ABCAM PLC: BUSINESS OVERVIEW
    • FIGURE 37 COMPANY SNAPSHOT: ABCAM PLC (2020)
    • 11.1.8 ENZO BIOCHEM, INC.
    • TABLE 305 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW
    • FIGURE 38 COMPANY SNAPSHOT: ENZO BIOCHEM, INC. (2020)
    • 11.1.9 LI-COR, INC.
    • TABLE 306 LI-COR, INC.: BUSINESS OVERVIEW
    • 11.1.10 ADVANSTA INC.
    • TABLE 307 ADVANSTA INC.: BUSINESS OVERVIEW
    • 11.1.11 CELL SIGNALING TECHNOLOGY, INC.
    • TABLE 308 CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW
    • 11.1.12 AZURE BIOSYSTEMS, INC.
    • TABLE 309 AZURE BIOSYSTEMS, INC.: BUSINESS OVERVIEW
    • 11.1.13 BOSTER BIOLOGICAL TECHNOLOGY
    • TABLE 310 BOSTER BIOLOGICAL TECHNOLOGY: BUSINESS OVERVIEW
    • 11.1.14 GENO TECHNOLOGY INC.
    • TABLE 311 GENO TECHNOLOGY INC.: BUSINESS OVERVIEW
    • 11.1.15 STRESSMARQ BIOSCIENCES INC.
    • TABLE 312 STRESSMARQ BIOSCIENCES INC.: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 11.2 OTHER COMPANIES
    • 11.2.1 F. HOFFMANN-LA ROCHE LTD.
    • 11.2.2 ROCKLAND IMMUNOCHEMICALS, INC.
    • 11.2.3 PRECISION BIOSYSTEMS
    • 11.2.4 CLEAVER SCIENTIFIC LTD.
    • 11.2.5 PROTEINTECH GROUP
    • 11.2.6 ABNOVA CORPORATION
    • 11.2.7 SINO BIOLOGICAL INC.
    • 11.2.8 ABBEXA LTD.
    • 11.2.9 COVALAB S.A.S.
    • 11.2.10 BIORBYT LTD.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS